US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

24.34

-0.7800-3.11%

Volume:10.59K

Turnover:260.33K

Market Cap:56.47M

PE:- -

High:25.32

Open:25.32

Low:24.34

Close:25.12

52wk High:27.02

52wk Low:15.63

Shares:2.32M

Float Shares:2.32M

Volume Ratio:2.35

T/O Rate:0.46%

Dividend:1.70

Dividend Rate:7.00%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Compass Pathways Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Compass Pathways Plc Files for Mixed Shelf Offering; Size not Disclosed - SEC Filing

THOMSON REUTERS

Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS), Geron (GERN) and Azenta (AZTA)

Compass Pathways PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Compass Pathways Publishes Investor Presentation on Comp360 Psilocybin Program, FDA Filing Progress and Launch Plans

Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs

Compass Pathways Q2 EPS $(1.88) Misses $(0.37) Estimate

Benzinga Earnings

Compass Pathways Q2 EPS USD -1.88

THOMSON REUTERS

Compass Pathways Q2 Operating Expenses USD 52.372 Million

THOMSON REUTERS

Press Release: Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

Heavy Rare Earths plans major equity raising via pro rata offer and placement

Heavy Rare Earths Limited launches $2.0m capital raising to fund drilling and project review

Relmada Therapeutics Inc Expected to Post a Loss of 20 Cents a Share - Earnings Preview

Iceni Gold Plans Share and Option Issue to Bolster Exploration Funding

Kuniko plans equity and option issue to bolster capital base

Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72

Alkermes Amends 8-K to Disclose CEO Blair Jackson Pay Package Including $5 Million Equity Award

Compass Pathways PLC Expected to Post a Loss of 40 Cents a Share - Earnings Preview

Patagonia Lithium shareholders back capital raising and option changes at 2026 meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/PSIL/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":24.34,"timestamp":1789481299114,"preClose":25.12,"halted":0,"volume":10590,"delay":0,"changeRate":-0.031050955414012784,"floatShares":2319976,"shares":2319976,"eps":0,"marketStatus":"Trading","change":-0.78,"latestTime":"09-15 10:08:38 EDT","open":25.3215,"high":25.3215,"low":24.34,"amount":260329.08801,"amplitude":0.039072,"askPrice":24.52,"askSize":100,"bidPrice":24.11,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":25.12,"sharesOutstanding":1184976,"nav":24.85,"aum":57650992.8,"dividendRate":0.069971,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.12,"preClose":25.12,"latestTime":"19:30 EDT","volume":167,"amount":4194.275,"timestamp":1789428602004,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.345266,"impliedVol":0.5485,"impliedVolPercentile":0.9044},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2319976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.345266,"shares":2319976,"dividePrice":1.7031,"high":25.3215,"amplitude":0.039072,"preClose":25.12,"low":24.34,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":24.34,"eps":0,"divideRate":0.069971,"volume":10590,"delay":0,"ttmEps":0,"open":25.3215,"prevYearClose":17.17,"prevWeekClose":24.7682,"prevMonthClose":24.62,"prevQuarterClose":24.05,"fiveDayClose":24.96,"twentyDayClose":25.83,"sixtyDayClose":20.0904},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657738605","title":"Compass Pathways Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657738605","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657738605?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:30","pubTimestamp":1785961801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUAMJ72R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657578488","title":"Compass Pathways Plc Files for Mixed Shelf Offering; Size not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2657578488","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657578488?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:23","pubTimestamp":1785961439,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN4421TK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657152527","title":"Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657152527","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657152527?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:01","pubTimestamp":1785960060,"startTime":"0","endTime":"0","summary":"Presented positive Phase 2 results for silevertinib in frontline patients with non-classical EGFRm NSCLC at the 2026 ASCO Annual Meeting, including that no patients developed de novo brain metastases ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/05/3339642/0/en/Black-Diamond-Therapeutics-Reports-Second-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC","PSIL","BDTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657522320","title":"Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS), Geron (GERN) and Azenta (AZTA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657522320","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657522320?lang=en_us&edition=fundamental","pubTime":"2026-08-06 02:50","pubTimestamp":1785955808,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on COMPASS Pathways (CMPS), Geron (GERN) and Azenta (AZTA). COMPASS ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-compass-pathways-cmps-geron-gern-and-azenta-azta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-compass-pathways-cmps-geron-gern-and-azenta-azta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1169589451.USD","HCSG","IE00B7SZL793.SGD","BK4588","BK4121","XLV","BK4581","BK4147","CMPS","IE00B19Z4B17.USD","LABU","LU0012050646.USD","LU1169590202.USD","PSIL","LU2065732104.USD","GERN","IE00B66KJ199.SGD","LU0128526141.USD","AZTA","BK4137","LU0106261612.USD","LU0029874061.USD","BK4139","IE0031619046.USD","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657540547","title":"Compass Pathways PLC Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657540547","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657540547?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:32","pubTimestamp":1785936746,"startTime":"0","endTime":"0","summary":"Compass Pathways PLC reports results for the quarter ended June 30 - Earnings SummaryCompass Pathways PLCCMPS.OQreported a quarterly adjusted loss of $1.88 per share for the quarter ended June 30, low","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N44224E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657544828","title":"Compass Pathways Publishes Investor Presentation on Comp360 Psilocybin Program, FDA Filing Progress and Launch Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2657544828","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657544828?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:07","pubTimestamp":1785931637,"startTime":"0","endTime":"0","summary":"Compass Pathways publishes investor presentation on COMP360 psilocybin program, FDA filing progress and launch plansCompass Pathways outlined plans to file a rolling NDA for COMP360 psilocybin in trea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL9WMrTH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PSIL","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657545831","title":"Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657545831","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657545831?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:45","pubTimestamp":1785926714,"startTime":"0","endTime":"0","summary":"Compass Pathways' Q2 loss widens on commercial readiness activity costsOverviewUK mental health biotech's Q2 operating income missed analyst estimatesNet loss widened yr/yr, mainly due to non-cash war","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4420FQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","LU1196032939.SGD","LU2125154935.USD","LU1291159041.SGD","LU0985481810.HKD","LU1153585028.USD","LU0211326839.USD","LU1057294990.SGD","IHE","LU0496365809.HKD","LU0757432116.USD","LIVN","LU1718418525.SGD","BK4007","FTXH","LU0310799852.SGD","LU1880407215.USD","LU1670710588.SGD","LU2596442595.SGD","LU0096364046.USD","PSIL","LU1046234339.USD","LU0575583348.USD","LU0997586432.USD","LU0203345920.USD","LU2065170008.USD","LU1585245621.USD","LU2089284900.SGD","LU2237443978.SGD","LU1273509221.SGD","SG9999013999.USD","LU2279689827.SGD","LU1983299246.USD","LU2539964713.USD","LU0266013472.USD","03165","ACAD","AZN.UK","LU1989772923.USD","LU1481600234.SGD","LU0321505868.SGD","SG9999001176.USD","LU0432979614.USD","LU0306807586.USD","SGXZ57979304.SGD","LU2065171311.SGD","LU1863844749.USD","CMPS","LU0526926950.USD","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657254330","title":"Compass Pathways Q2 EPS $(1.88) Misses $(0.37) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657254330","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657254330?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:33","pubTimestamp":1785925989,"startTime":"0","endTime":"0","summary":"Compass Pathways (NASDAQ:CMPS) reported quarterly losses of $(1.88) per share which missed the analyst consensus estimate of $(0.37) by 408.11 percent. This is a 358.54 percent decrease over losses of $(0.41) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60941435/compass-pathways-q2-eps-1-88-misses-0-37-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657548774","title":"Compass Pathways Q2 EPS USD -1.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2657548774","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657548774?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:30","pubTimestamp":1785925800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLXD2DKG4:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657548002","title":"Compass Pathways Q2 Operating Expenses USD 52.372 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657548002","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657548002?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:30","pubTimestamp":1785925800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLXD2DKG4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657354829","title":"Press Release: Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2657354829","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657354829?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:30","pubTimestamp":1785925800,"startTime":"0","endTime":"0","summary":"--  Data from two positive Phase 3 trials demonstrated rapid onset of. effect and durable benefit through at least 6 months, further validating. COMP360's potential to establish a new standard of care in TRD. --  COMP360 has a highly differentiated clinical profile and is expected to. --  Rolling NDA submission and initial review underway and final submission. --  Commercial launch expected in first half of 2027. --  COMP360 expected to fit seamlessly into current treatment. --  Strong cash position of $433 million at the end of second quarter,--  Compass management will host a conference call on August 5 at 8:00 am. options in mental health care -- moving beyond daily or frequent. administration toward an option that could potentially provide strong. efficacy with just a few treatments a year that could be life changing. --  Across two highly statistically significant positive Phase 3 trials,COMP360 is the first classic psychedelic1 to consistently demonstrate. rapid onset, sustained ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NPV","BK4223","PSIL","BK4194","BK4139","CMPS","DEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657951495","title":"Heavy Rare Earths plans major equity raising via pro rata offer and placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2657951495","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657951495?lang=en_us&edition=fundamental","pubTime":"2026-08-05 08:37","pubTimestamp":1785890250,"startTime":"0","endTime":"0","summary":"Heavy Rare Earths Limited ( ($AU:HRE) ) has issued an announcement. Heavy Rare Earths Limited has lodged details of a proposed capital raising with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/heavy-rare-earths-plans-major-equity-raising-via-pro-rata-offer-and-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/heavy-rare-earths-plans-major-equity-raising-via-pro-rata-offer-and-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SETM","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657595104","title":"Heavy Rare Earths Limited launches $2.0m capital raising to fund drilling and project review","url":"https://stock-news.laohu8.com/highlight/detail?id=2657595104","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657595104?lang=en_us&edition=fundamental","pubTime":"2026-08-05 08:37","pubTimestamp":1785890234,"startTime":"0","endTime":"0","summary":"Heavy Rare Earths Limited ( ($AU:HRE) ) just unveiled an update. Heavy Rare Earths Limited has launched a capital raising of up to $2.028 million v...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/heavy-rare-earths-limited-launches-2-0m-capital-raising-to-fund-drilling-and-project-review?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/heavy-rare-earths-limited-launches-2-0m-capital-raising-to-fund-drilling-and-project-review?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SETM","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657600845","title":"Relmada Therapeutics Inc Expected to Post a Loss of 20 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657600845","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657600845?lang=en_us&edition=fundamental","pubTime":"2026-08-05 06:10","pubTimestamp":1785881405,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc <RLMD.OQ> expected to post a loss of20cents a share - Earnings PreviewRelmada Therapeutics IncRLMD.OQRLMD.Ois expected to  show no change in quarterly revenue when it reports ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N4413EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","RLMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588643","title":"Iceni Gold Plans Share and Option Issue to Bolster Exploration Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588643","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588643?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:24","pubTimestamp":1785799494,"startTime":"0","endTime":"0","summary":"Iceni Gold Ltd. ( ($AU:ICL) ) has issued an update. Iceni Gold Ltd has outlined plans for a new capital raising via a proposed placement or similar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/iceni-gold-plans-share-and-option-issue-to-bolster-exploration-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/iceni-gold-plans-share-and-option-issue-to-bolster-exploration-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["159934","518880","SGCmain","IAU","GLD","PSIL","SGUmain","NUGT","DUST","GCmain","GDX","MGCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588694","title":"Kuniko plans equity and option issue to bolster capital base","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588694","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588694?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:24","pubTimestamp":1785799458,"startTime":"0","endTime":"0","summary":"Kuniko Ltd. ( ($AU:KNI) ) has shared an update. Kuniko Limited has lodged a new Appendix 3B with the ASX outlining a proposed capital raising throu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kuniko-plans-equity-and-option-issue-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kuniko-plans-equity-and-option-issue-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300056","title":"Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300056","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300056?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:10","pubTimestamp":1785798604,"startTime":"0","endTime":"0","summary":"Alkermes EVP, CLO David Joseph Gaffin sells 2,034 shares for $98,821.72David Joseph Gaffin, EVP and chief legal officer, sold 2,034 ordinary shares on Aug. 3, 2026 at USD 48.58.His direct stake fell t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL9zXC08:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBT","PSIL","IBRN","ALKS","MEDX","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656019363","title":"Alkermes Amends 8-K to Disclose CEO Blair Jackson Pay Package Including $5 Million Equity Award","url":"https://stock-news.laohu8.com/highlight/detail?id=2656019363","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656019363?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:09","pubTimestamp":1785787780,"startTime":"0","endTime":"0","summary":"Alkermes amends 8-K to disclose CEO Blair Jackson pay package including $5 million equity awardAlkermes amended a Feb. 25 Form 8-K on its CEO succession to add previously undetermined compensation ter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL2dlwWm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","PSCH","ALKS","IBRN","BK4139","PSIL","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656537177","title":"Compass Pathways PLC Expected to Post a Loss of 40 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656537177","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656537177?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:11","pubTimestamp":1785762665,"startTime":"0","endTime":"0","summary":"Compass Pathways PLC <CMPS.OQ> expected to post a loss of40cents a share - Earnings PreviewCompass Pathways PLCCMPS.OQCMPS.Ois expected to  show no change in quarterly revenue when it reports  results","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4401E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656834496","title":"Patagonia Lithium shareholders back capital raising and option changes at 2026 meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2656834496","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656834496?lang=en_us&edition=fundamental","pubTime":"2026-08-03 09:47","pubTimestamp":1785721651,"startTime":"0","endTime":"0","summary":"Patagonia Lithium Limited ( ($AU:PL3) ) just unveiled an update. Patagonia Lithium Ltd has reported that all resolutions put to shareholders at its...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/patagonia-lithium-shareholders-back-capital-raising-and-option-changes-at-2026-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/patagonia-lithium-shareholders-back-capital-raising-and-option-changes-at-2026-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BK4585","BK4588","LIT","SETM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}